title: Open letter: European Medicines Agency should remove barriers to access clinical trial data.
authors.forename: Ben
authors.initials: B
authors.lastname: Goldacre
authors.forename: Fiona
authors.initials: F
authors.lastname: Godlee
authors.forename: Carl
authors.initials: C
authors.lastname: Heneghan
authors.forename: David
authors.initials: D
authors.lastname: Tovey
authors.forename: Richard
authors.initials: R
authors.lastname: Lehman
authors.forename: Iain
authors.initials: I
authors.lastname: Chalmers
authors.forename: Virginia
authors.initials: V
authors.lastname: Barbour
authors.forename: Tracey
authors.initials: T
authors.lastname: Brown
mesh_terms: D022126:Access to Information; D002986:Clinical Trials as Topic; D005060:Europe; D009938:Organizations; D004364:Pharmaceutical Preparations
chemical_list: D004364:Pharmaceutical Preparations